Microsomal cytochrome P450c17 catalyzes both steroid 17a-hydroxylase activity and scission of the C17-C20 steroid bond (17,20-lyase) on the same active site. Adrenal 17a-hydroxylase activity is needed to produce cortisol throughout life, but 17,20-lyase activity appears to be controlled independently in a complex, age-dependent pattern. We show that human P45Oc17 is phosphorylated on serine and threonine residues by a cAMP-dependent protein kinase. Phosphorylation of P450c17 increases 17,20-lyase activity, while dephosphorylation virtually eliminates this activity. Hormonally regulated serine phosphorylation of human P45Oc17 suggests a possible mechanism for human adrenarche and may be a unifying etiologic link between the hyperandrogenism and insulin resistance that characterize the polycystic ovary syndrome.
The synthesis of sex steroids from pregnenolone or progesterone first requires the 17a-hydroxylation of these steroids to 17a-hydroxypregnenolone and 17a-hydroxyprogesterone, respectively. The C17-C20 carbon bond of either of these 21-carbon steroids is then cleaved to yield the 19-carbon androgens dehydroepiandrosterone (DHEA) and androstenedione, respectively, which are then converted to testosterone and estradiol. Both the 17a-hydroxylation of pregnenolone and progesterone and the subsequent C17-C20 bond cleavage (17, 20 -lyase activity) of 17a-hydroxypregnenolone and 17a-hydroxyprogesterone are catalyzed by a single enzyme, cytochrome P450c17. Only a single enzyme catalyzing 17a-hydroxylase activity and 17,20-lyase activity can be isolated from steroidogenic tissues (1) (2) (3) (4) , and transfection of vectors expressing the cDNAs for either bovine (5) or human (6) P450c17 confers both 17a-hydroxylase and 17,20-lyase activity to the transfected cells. There is only one human gene for P450c17 (7) located on chromosome 10q24-q25 (8) , and mutations of this gene can destroy all 17a-hydroxylase and 17,20-lyase activity (6, (9) (10) (11) (12) . Thus it is clear that there is only one enzyme catalyzing both of these activities.
In the testis, all of the precursor steroids are converted to sex steroids-i.e., the effective ratio of lyase activity to hydroxylase activity is unity. However, in the human adrenal cortex, this ratio is under closely regulated control during development. The adrenals of children between 1 and 8 years of age make cortisol (a C21 steroid) but virtually no C19 steroids. Between 7 and 9 years, the adrenals begin to produce DHEA associated with increased adrenal l7c7-hydroxylase and 17,20-lyase activity (13) and without an associated change in the secretion of cortisol or adrenocorticotropic hormone (14, 15) . DHEA secretion increases steadily, reaching maximal levels at [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] years, and afterwards wanes slowly, returning to childhood levels at 70-80 years (16) . This onset of adrenal androgen synthesis, an event termed adrenarche, is independent of the gonads or pituitary gonadotropins (17) and only occurs in humans and other higher primates (14) . While it has been suggested that adrenal androgens are under the control of a specific pituitary tropic hormone (15, 17) , no such hormone has been found (18) (19) (20) . Other efforts have focused on possible intraadrenal events such as adrenal mass, blood flow, and intra-adrenal steroid concentrations that might affect adrenal androgen production (21) . An especially intriguing approach was suggested by the observation that increasing the molar ratio of isolated, purified electron donors, such as P450 oxidoreductase (OR) or cytochrome b5, to porcine P450c17 would increase the ratio of lyase to hydroxylase activity (22) . Experiments with transfected COS-1 cells confirm that coexpression of vectors encoding human OR and human P450c17 results in a substantial increase in 17,20-lyase activity (23).
However, it seems unlikely that adrenarche could result from a large increase in the expression of an electron donor, as the activity of adrenal cytochrome P450c21 (steroid 21-hydroxylase), which uses the same electron donors, is unchanged during adrenarche.
Studies of the contribution of various residues in P450c17 suggest that specific amino acids are uniquely required for 17,20-lyase activity: the mutation R346A in rat P450c17 (24) or the corresponding mutant R347A in human P450c17 (25) destroys virtually all 17,20-lyase activity while having minimal effects on 17a-hydroxylase activity. Other subtle mutations can also affect this ratio (23) (24) (25) (26) . As the amino acid sequence of P450c17 cannot change with adrenarche, we have thus considered whether posttranslational modification of P450c17 could alter the ratio of hydroxylase to lyase activity.
We now report that serine phosphorylation of human P450c17 appears to be required for 17,20-lyase activity. We hypothesize that this phosphorylation is developmentally regulated in the adrenal cortex in response to as yet unidentified stimuli, thus suggesting a mechanism for the onset of adrenarche. Furthermore, the association of serine phosphorylation with the induction of androgen synthesis suggests a unifying hypothesis for the two cardinal features of some forms of the polycystic ovary syndrome (i.e., hyperandrogenism and insulin resistance), as serine phosphorylation of the insulin receptor can cause insulin resistance (27, 28) .
MATERIALS AND METHODS
Cell Culture and Immunoprecipitations. COS-1 African green monkey kidney cells were grown in monolayer in 10-cm dishes in 10 ml of Dulbecco's modified Eagle's medium/Ham's 21 (DME-H21) containing 4.5 g of glucose per liter and 10% fetal bovine serum and were transfected as described (6) .
NCI-H295 human adrenocortical carcinoma cells were grown as described (29, 30) 140 ,000 x g. The supernatant was precleared with protein A-Sepharose CL-4B beads (Pharmacia) before adding antiserum to human P450c17 (23) at a dilution of 1:300. The immune complexes were harvested with protein A-Sepharose CL-4B beads, washed extensively, and analyzed by electrophoresis on SDS/10% polyacrylamide gels. Western immunoblotting of one-and two-dimensional gels was done as described (23, 33) .
Plasmids, Transfections, and Enzyme Assays. The human P450c17 cDNA (34) was subcloned into the expression vector pMT2 (35) . The expression vector for the catalytic subunit of cAMP-dependent PKA (RSV-CatI3) (36) was generously provided by Richard A. Maurer. Plasmids (2 ,g) purified by CsCl banding were transfected overnight into COS-1 cells by calcium phosphate precipitates as described (37) . After changing the medium, cells were incubated 48 h, washed twice with PBS, washed twice with DME-H21 lacking phosphate or methionine, and then were used for metabolic labeling as above or for enzymatic hormonal conversion assays. Enzymatic assays used [3H]pregnenolone (925 GBq/mmol; DuPont/NEN) or 17a-[3H]hydroxypregnenolone (618 GBq/ mmol; Amersham) in DME-H21 containing 10% fetal calf serum. Steroids were extracted and analyzed by TLC exactly as described (6, 23) .
Phosphoamino Acid Analysis. 32P-labeled human P450c17 was isolated by immunoprecipitation with rabbit anti-human P450c17 and protein A-Sepharose CL-4B as described above, then displayed by electrophoresis on an SDS/10% polyacrylamide gel, and electroblott.ed to nitrocellulose membranes.
The P450c17 band was cut out, digested with trypsin, then hydrolyzed with 5.7 M HCl, and analyzed by thin-layer electrophoresis in two dimensions at pH 1.9 and pH 3.5. Autoradiograms were compared to the ninhydrin-stained plates, all as described (38, 39) .
Microsomal Assays. Human fetal adrenal microsomes were prepared by homogenizing 300 mg of tissue in 2 ml of 0.25 M sucrose/5 mM EDTA, pH 7.4, clearing debris at 9000 x g for 20 min, and centrifuging at 105,000 x g for 1 h. The crude pellet was washed in 0.1 M KXPO4 buffer, pH 7.4/0.1 mM EDTA; the microsomes were harvested at 105,000 x g for 1 h, resuspended in 3 ml of 0.1 M KXPO4 buffer/0.1 mM EDTA/ 20% (vol/vol) glycerol, and stored at -20°C. The protein content was 2.6 mg/ml, and the P450 content measured by CO-difference spectra using a millimolar extinction of As450o 490 = 91 mM-1cm-1 (40) (Fig. 3, lanes 1-7) . Similarly, when this P450c17 vector was cotransfected with a vector expressing the catalytic subunit of PKA (RSV-Cat,B) (36), the incorporation of 32P, increased about 2-fold (Fig. 3, lanes 8 and 9) lack the regulatory subunit of PKA (32) . After transfection with the P450c17 expression vector, incubation of Kin 8 cells with 32p; yielded no detectable 32P-labeled P450c17, and cotransfection with RSV-Catf3 yielded minimally detectable 32P-labeled P450c17 (lanes 12 and 13) . Thus P450c17 appears to be phosphorylated in a cAMP-dependent fashion, but PKA appears to play a relatively minor role in this phosphorylation.
P450c17 Is Phosphorylated at Serine (and Threonine) Residues. The apparent role of PKA in P450c17 phosphorylation would suggest that P450c17 might be phosphorylated at serine and possibly threonine residues. To determine the chemical identity of the phosphorylated residues, we performed two-dimensional phosphoamino acid analysis (39) . Direct HCl treatment of the P450c17 phosphoprotein isolated from an SDS gel did not yield complete hydrolysis; however, when the protein was first digested with trypsin, followed by HCl, complete hydrolysis was achieved. As shown in Fig. 4 , about 70-80% of the 32p was associated with serine residues, and the remainder was associated with threonine residues, whereas there was no detectable radioactivity associated with tyrosine residues.
Phosphorylation of P450c17 Increases 17,20-Lyase Activity. Our previous data show that cotransfection of a vector expressing OR, the protein that normally donates electrons to P450c17, into COS-1 cells with a P450c17 expression vector will increase the 17,20-lyase activity of the expressed P450c17 (23) . Incubation of transfected COS-1 cells with 32p; showed that cotransfection with the OR expression vector did not increase or decrease the phosphorylation of P450c17 (data not shown). To assess the influences of OR and of PKA, cells were incubated with [14C]pregnenolone, and the production of 17a-hydroxypregnenolone and DHEA were assessed by TLC and scintillation counting of the appropriate spots. Cotransfection with either RSV-Cat,B or OR increased the 17,20-lyase activity of P450c17, but the combination of OR and RSV-Cat,3 did not increase lyase activity further (Fig. 5) . Thus phosphorylation of P450c17 appears to increase the efficiency of electron transfer, possibly by increasing the affinity of P450c17 for OR.
Dephosphorylation of P450c17 Reduces 17,20-Lyase Activity. The induction of 17,20-lyase activity in cells treated with cAMP was often difficult to assess because untreated cells retained some 17,20-lyase activity and some phosphorylation of P450c17. Therefore, we also assessed the effect of dephosphorylation of P450c17 in vitro. Microsomal preparations of transfected cells did not contain enough total P450 to permit measurement by CO-difference spectra (data not shown), but microsomes from human fetal adrenal tissue yielded about 1 nmol of P45f0 protein per milligram of total protein. When adrenal microsomes were incubated with [3H]pregnenolone or 17a-[3H]hydroxypregnenolone, they exhibited both 17ca-hydroxylase and 17,20-lyase activity. However when microsomal proteins were dephosphorylated with alkaline phosphatase, the microsomes lost 17,20-lyase activity, but not 17a-hydroxylase activity, in a time-dependent fashion (Fig. 6) . As P450c17 activity requires electrons donated by microsomal OR, we determined whether alkaline phosphatase affected this enzyme. Even twice the amount of alkaline phosphatase used above had no effect on OR activity (Fig. 6B) . The persistence of 17a-hydroxylase and OR activities after treat- ment with alkaline phosphatase shows that the loss of 17,20-lyase activity was not due to proteolysis [as suggested (45) ]. Similarly the persistence of 17a-hydroxylase activity with both pregnenolone and progesterone substrates, an activity that requires NADPH, shows that the alkaline phosphataseinduced loss of 17,20-lyase activity was not due to dephosphorylation of this cofactor. Alkaline phosphatase treatment also did not alter the substrate-induced difference spectrum of total microsomal P450 incubated with either pregnenolone or 17a-hydroxypregnenolone (Fig. 7) . Thus alkaline phosphatase treatment did not degrade P450c17, and dephosphorylation of P450c17 diminished 17,20-lyase activity without altering the substrate binding.
DISCUSSION
Adrenarche is a developmentally programmed increase in 17,20-lyase activity. To date, no mechanism for adrenarche has been proposed that accounts for a large increase in 17,20-lyase activity without altering 17a-hydroxylase activity. We now propose that serine/threonine phosphorylation of adrenal P450c17 by a cAMP-dependent kinase can account for the available observations concerning adrenarche and several related phenomena. Previous studies show that additional reducing equivalents are required for 17,20-lyase activity-e.g, from P450 oxidoreductase or cytochrome b5 (22, 23, 46, 47) . The phosphorylation of P450c17 obviously does not directly provide the increased reducing equivalents needed for 17,20-lyase activity but may increase the affinity of P450c17 for the electron donor. A related example appears to be the R346A mutation in rat P450c17 (R347A in human), which selectively destroys 17,20-lyase activity while retaining 17a-hydroxylase activity (24, 25 proximal face of the enzyme where it would participate in the initial charge recognition and binding between P450 reductase and the enzyme (25, 48) . Similarly, phosphorylation of P450c17 may increase its electrostatic affinity for electron donors, thus favoring 17,20-lyase activity.
While the physiologic trigger to adrenarche and/or P450c17 phosphorylation remains unknown, we would speculate that insulin-like growth factor I (IGF-I) may be a good candidate.
Serum levels of IGF-I rise and fall in a pattern that is contemporaneous with DHEA secretion. Both insulin and IGF-I transmit their signals by initiating tyrosine autophosphorylation of the insulin/IGF-I receptors, whereas the phosphorylation of serine and threonine residues diminishes signal transduction (27, 28 
